The COVID-19 pandemic continues to go on and while the world is slowly coming out of the previously imposed strict lockdown, things
Moderna Inc
-(MRNA)
Moderna, Inc. (MRNA) Q2 2020 Earnings Conference Call Transcript
Moderna Inc. (NASDAQ: MRNA) Q2 2020 earnings call dated Aug. 05, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief Executive
Moderna impresses on the financial side as well in Q2
Moderna, Inc., (Nasdaq: MRNA), a prime contender in Covid-19 vaccine research, on Wednesday, reported second-quarter financial results that smashed past analysts’ estimates.
Moderna Inc (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call Transcript
Moderna Inc (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call dated July 15, 2020 Corporate Participants: Lavina Talukdar -- Head
Moderna medical chief: Varying infection rate to be the biggest challenge in Phase 3
A diverse population with varying infection rates will be among the biggest challenges during the phase 3 trials of its COVID-19 vaccine
Rallies you may have missed: 6 stocks that soared in 2020
This year, we saw long red candles replacing clowns as the ultimate symbol of horror. It has given sleepless nights to not
Moderna Inc (NASDAQ: MRNA) Q1 2020 Earnings Call Transcript
Moderna Inc (MRNA) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief Executive Officer
Moderna (NASDAQ: MRNA) SARS-CoV-2 Vaccine Interim Phase 1 Data Call Transcript
Moderna Inc (MRNA) Q1 2019 interim phase 1 data conference call dated May. 18, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations